1. Home
  2. MDBH vs CELU Comparison

MDBH vs CELU Comparison

Compare MDBH & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$2.98

Market Cap

36.7M

Sector

N/A

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.27

Market Cap

35.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
CELU
Founded
1997
2016
Country
United States
United States
Employees
N/A
123
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
35.2M
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
MDBH
CELU
Price
$2.98
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
5.1K
104.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$76.00
P/E Ratio
$4.06
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.80
$1.01
52 Week High
$6.60
$4.35

Technical Indicators

Market Signals
Indicator
MDBH
CELU
Relative Strength Index (RSI) 44.73 48.65
Support Level $2.80 $1.21
Resistance Level $3.84 $1.33
Average True Range (ATR) 0.11 0.11
MACD -0.01 0.00
Stochastic Oscillator 45.37 49.96

Price Performance

Historical Comparison
MDBH
CELU

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: